• 1. College of Medicine, Xizang University, Lhasa 850000, China;
  • 2. Department of Neurology, Xizang Autonomous Region People’s Hospital, , Lhasa 850000, China;
ZHAO Yuhua, Email: drolyang@163.com
Export PDF Favorites Scan Get Citation

Epilepsy is a chronic neurological disorder resulting from abnormal neuronal discharges in the brain. China has an estimated 10 million people with epilepsy, nearly half of whom are women of reproductive age. The disease significantly affects patients' fertility, pregnancy safety, and delivery outcomes, necessitating specialized cross-cycle health management, with most patients requiring continuous antiseizure medication during pregnancy. Lamotrigine (LTG), levetiracetam (LEV), and oxcarbazepine (OXC) are preferred pharmacological options during gestation due to their lower teratogenic risks. This review focuses on the holistic management of women with epilepsy (WWE) and the application of antiseizure medications (ASMs), aiming to provide evidence-based strategies for clinical practice.

Citation: WANG Wenqing, ZHAO Yuhua. The research progress of the management and treatment of women with epilepsy. Journal of Epilepsy, 2026, 12(1): 51-58. doi: 10.7507/2096-0247.202507002 Copy

Copyright ? the editorial department of Journal of Epilepsy of West China Medical Publisher. All rights reserved

  • Previous Article

    Application of magnetoencephalography technology in the diagnosis and treatment of pediatric epilepsy
  • Next Article

    Cognitive and language obstruction with temporal lobe epilepsy